Meningioma mouse models

Journal of Neuro-Oncology

Volumn 99, Issue 3, 2010, Pages 325-331

  Kalamarides, Michel ^a,b,c   Peyre, Matthieu ^a,b,c   Giovannini, Marco ^d  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DIDEROT   (France)

^d HOUSE EAR INSTITUTE   (United States)

Author keywords

Arachnoid; Brain tumor; Mouse model; NF2; Transgenic mice

Indexed keywords

CELECOXIB; DILTIAZEM; EPITHELIAL MEMBRANE ANTIGEN; ETHYLNITROSOUREA; IRINOTECAN; MIFEPRISTONE; NEUROFIBROMATOSIS TYPE 2 PROTEIN; NITROSOUREA; PEGVISOMANT; TUMOR PROTEIN; UNCLASSIFIED DRUG; VERAPAMIL; VEROTOXIN;

ANTINEOPLASTIC ACTIVITY; BRAIN ARACHNOID; BRAIN CELL; CLINICAL STUDY; DRUG EFFICACY; GENE FUNCTION; GENE LOSS; GENETIC ENGINEERING; HUMAN; IMMUNOHISTOCHEMISTRY; MENINGIOMA; MOLECULAR GENETICS; MUTAGENESIS; NEUROPATHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; ORTHOTOPIC TRANSPLANTATION; PRIMARY TUMOR; REVIEW; SINGLE DRUG DOSE; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; XENOTRANSPLANTATION;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MENINGEAL NEOPLASMS; MENINGIOMA; MICE;

EID: 77957596002     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0331-5     Document Type: Review

References (50)

1. MK Aghi BS Carter GR Cosgrove, et al. 2009 Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation Neurosurgery 64 56 60 10.1227/01.NEU.0000330399.55586.63 19145156 discussion 60
2. SY Yang CK Park SH Park, et al. 2008 Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features J Neurol Neurosurg Psychiatry 79 574 580 10.1136/jnnp.2007.121582 17766430 (Pubitemid 351571878)
3. DG Evans SM Huson D Donnai, et al. 1992 A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity J Med Genet 29 841 846 1:STN:280:DyaK3s7isVCksQ%3D%3D 10.1136/jmg.29.12.841 1479598
4. DH Gutmann MJ Giordano AS Fishback A Guha 1997 Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas Neurology 49 267 270 1:STN:280:DyaK2szmsFeluw%3D%3D 9222206
5. A Perry DX Cai BW Scheithauer, et al. 2000 Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases J Neuropathol Exp Neurol 59 872 879 1:CAS:528:DC%2BD3cXotVKnu74%3D 11079777
6. WH Lee 1990 Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee Neurosurgery 27 389 395 1:CAS:528:DyaK38XltVahtLc%3D 10.1097/00006123-199009000-00008 2234331 discussion 396
7. JC Tsai CK Goldman GY Gillespie 1995 Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF J Neurosurg 82 864 873 1:CAS:528:DyaK2MXmt1eru7o%3D 10.3171/jns.1995.82.5.0864 7714613
8. BT Ragel WT Couldwell DL Gillespie, et al. 2008 A comparison of the cell lines used in meningioma research Surg Neurol 70 295 307 10.1016/j.surneu.2007. 06.031 18261772 discussion 307
9. M Sasaki T Honda H Yamada, et al. 1994 Evidence for multiple pathways to cellular senescence Cancer Res 54 6090 6093 1:CAS:528:DyaK2MXisVSqsbk%3D 7954452
10. P Leuraud E Dezamis L Aguirre-Cruz, et al. 2004 Prognostic value of allelic losses and telomerase activity in meningiomas J Neurosurg 100 303 309 1:CAS:528:DC%2BD2cXhs1GjtbY%3D 10.3171/jns.2004.100.2.0303 15098535
11. LA Langford MA Piatyszek R Xu, et al. 1997 Telomerase activity in ordinary meningiomas predicts poor outcome Hum Pathol 28 416 420 1:CAS:528:DyaK2sXjtFWmsLk%3D 10.1016/S0046-8177(97)90029-0 9104940 (Pubitemid 27175081)
12. L Boldrini S Pistolesi S Gisfredi, et al. 2003 Telomerase in intracranial meningiomas Int J Mol Med 12 943 947 1:CAS:528:DC%2BD3sXpvFant7c%3D 14612971
13. L Maes E Lippens JP Kalala L de Ridder 2005 The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas Cell Prolif 38 3 12 1:CAS:528:DC%2BD2MXit1Grtro%3D 10.1111/j.1365-2184.2005.00325.x 15679862 (Pubitemid 40229263)
14. GS Baia AL Slocum JD Hyer, et al. 2006 A genetic strategy to overcome the senescence of primary meningioma cell cultures J Neurooncol 78 113 121 1:CAS:528:DC%2BD28XotFeitbk%3D 10.1007/s11060-005-9076-y 16554968 (Pubitemid 44339678)
15. TG Cargioli HC Ugur N Ramakrishna, et al. 2007 Establishment of an in vivo meningioma model with human telomerase reverse transcriptase Neurosurgery 60 750 759 10.1227/01.NEU.0000255397.00410.8F 17415213 discussion 759-760
16. S Puttmann V Senner S Braune, et al. 2005 Establishment of a benign meningioma cell line by hTERT-mediated immortalization Lab Invest 85 1163 1171 10.1038/labinvest.3700307 15965488 (Pubitemid 43073988)
17. HSN Greene H Arnold 1945 The homologous and heterologous transplantation of brain and brain tumors J Neurosurg 2 315 329 10.3171/jns.1945.2.4.0315
18. MW Rana H Pinkerton H Thornton D Nagy 1977 Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice Proc Soc Exp Biol Med 155 85 88 1:STN:280:DyaE2s7ntlWitw%3D%3D 193127
19. Y Ueyama K Morita C Ochiai, et al. 1978 Xenotransplantation of a human meningioma and its lung metastasis in nude mice Br J Cancer 37 644 647 1:STN:280:DyaE1c7msF2jtw%3D%3D 646935
20. A Medhkour M Van Roey RA Sobel, et al. 1989 Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth J Neurosurg 71 545 550 1:STN:280:DyaK3c%2FhtFejsg%3D%3D 10.3171/jns.1989.71.4.0545 2477514
21. RL Jensen D Leppla N Rokosz RD Wurster 1998 Matrigel augments xenograft transplantation of meningioma cells into athymic mice Neurosurgery 42 130 135 1:STN:280:DyaK1c7gsVKjtQ%3D%3D 10.1097/00006123-199801000-00027 9442514 discussion 135-136 (Pubitemid 28067035)
22. GM Malham RJ Thomsen BJ Synek BC Baguley 2001 Establishment of primary human meningiomas as subcutaneous xenografts in mice Br J Neurosurg 15 328 334 1:STN:280:DC%2BD3Mrlt1GgsA%3D%3D 10.1080/02688690120082378 11599449 (Pubitemid 33701896)
23. IE McCutcheon KE Friend TM Gerdes, et al. 2000 Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth J Neurosurg 92 306 314 1:STN:280:DC%2BD3c7it1Whuw%3D%3D 10.3171/jns.2000.92.2.0306 10659019
24. WR van Furth S Laughlin MD Taylor, et al. 2003 Imaging of murine brain tumors using a 1.5 Tesla clinical MRI system Can J Neurol Sci 30 326 332 14672264
25. GS Baia EB Dinca T Ozawa, et al. 2008 An orthotopic skull base model of malignant meningioma Brain Pathol 18 172 179 1:CAS:528:DC%2BD1cXmtFGqt78%3D 10.1111/j.1750-3639.2007.00109.x 18093250 (Pubitemid 351430395)
26. BT Ragel IL Elam DL Gillespie, et al. 2008 A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation J Neurosurg 108 304 310 10.3171/JNS/2008/108/2/0304 18240927 (Pubitemid 351213295)
27. IE McCutcheon A Flyvbjerg H Hill, et al. 2001 Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice J Neurosurg 94 487 492 1:CAS:528:DC%2BD3MXhvFKgtbc%3D 10.3171/jns.2001.94. 3.0487 11235955
28. B Salhia JT Rutka C Lingwood A Nutikka WR Van Furth 2002 The treatment of malignant meningioma with verotoxin Neoplasia 4 304 311 1:CAS:528: DC%2BD38XkslKntb8%3D 10.1038/sj.neo.7900243 12082546 (Pubitemid 34755840)
29. V Gupta YS Su CG Samuelson, et al. 2007 Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas J Neurosurg 106 455 462 10.3171/jns.2007.106.3.455 17367069
30. BT Ragel RL Jensen DL Gillespie SM Prescott WT Couldwell 2007 Celecoxib inhibits meningioma tumor growth in a mouse xenograft model Cancer 109 588 597 1:CAS:528:DC%2BD2sXitV2it7w%3D 10.1002/cncr.22441 17177201 (Pubitemid 46190968)
31. JJ Olson DW Beck JA Schlechte PM Loh 1987 Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice J Neurosurg 66 584 587 1:STN:280:DyaL2s7mvVKqtg%3D%3D 10.3171/jns.1987.66.4.0584 3559725
32. RL Jensen RD Wurster 2001 Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice Surg Neurol 55 275 283 1:STN:280:DC%2BD3MvntVSmsw%3D%3D 10.1016/S0090-3019(01)00444-X 11516467 (Pubitemid 32564852)
33. MC Chamberlain DD Tsao-Wei S Groshen 2004 Temozolomide for treatment-resistant recurrent meningioma Neurology 62 1210 1212 1:CAS:528:DC%2BD2cXktFGjtLo%3D 15079029
34. JM Rice JD Wilbourn 2000 Tumors of the nervous system in carcinogenic hazard identification Toxicol Pathol 28 202 214 1:CAS:528:DC%2BD3cXpvVCmtw%3D%3D 10.1177/019262330002800125 10669008
35. JP Morrison H Satoh J Foley, et al. 2007 N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)/p19(ARF) tumor suppressor gene-deficient mice Toxicol Pathol 35 780 787 10.1080/ 01926230701584130 17943659 (Pubitemid 47613613)
36. AM Avellino LS Hair WF Symmans, et al. 1994 Meningeal meningiomatosis in a child: case report Clin Neuropathol 13 82 87 1:STN:280:DyaK2c3msFektw%3D%3D 8205731
37. K Wakabayashi K Kawasaki K Ono, et al. 1997 Primary leptomeningeal meningiomatosis with widespread whorl formation Brain Tumor Pathol 14 139 143 1:STN:280:DC%2BD2M%2Fps1Cgtw%3D%3D 10.1007/BF02478883 15726793
38. E Balme DR Roth E Perentes 2008 Cerebral meningioangiomatosis in a CD-1 mouse: a case report and comparison with humans and dogs Exp Toxicol Pathol 60 247 251 10.1016/j.etp.2008.03.003 18524558
39. A Perry O Kurtkaya-Yapicier BW Scheithauer, et al. 2005 Insights into meningioangiomatosis with and without meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature Brain Pathol 15 55 65 10.1111/j.1750-3639.2005.tb00100.x 15779237
40. KR Thomas MR Capecchi 1987 Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells Cell 51 503 512 1:CAS:528:DyaL1cXhsFGg 10.1016/0092-8674(87)90646-5 2822260
41. R Ramirez-Solis P Liu A Bradley 1995 Chromosome engineering in mice Nature 378 720 724 1:CAS:528:DyaK2MXhtVSnt7rF 10.1038/378720a0 7501018 (Pubitemid 26001943)
42. AI McClatchey I Saotome K Mercer, et al. 1998 Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors Genes Dev 12 1121 1133 1:CAS:528:DyaK1cXivFClsrY%3D 10.1101/gad.12.8.1121 9553042
43. M Giovannini E Robanus-Maandag M van der Valk, et al. 2000 Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2 Genes Dev 14 1617 1630 1:CAS:528:DC%2BD3cXkvFCku7s%3D 10887156
44. M Kalamarides M Niwa-Kawakita H Leblois, et al. 2002 Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse Genes Dev 16 1060 1065 1:CAS:528:DC%2BD38XjvV2ku74%3D 10.1101/gad.226302 12000789 (Pubitemid 34507195)
45. T Yamashima K Sakuda Y Tohma, et al. 1997 Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process J Neurosci 17 2376 2382 1:CAS:528:DyaK2sXitV2isrk%3D 9065498
46. M Kawashima SO Suzuki T Yamashima M Fukui T Iwaki 2001 Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma Mod Pathol 14 197 201 1:STN:280:DC%2BD3M7ntVWhug%3D%3D 10.1038/modpathol.3880285 11266526 (Pubitemid 32246824)
47. M Kalamarides AO Stemmer-Rachamimov M Takahashi, et al. 2008 Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations Brain Pathol 18 62 70 10.1111/j.1750-3639.2007.00105.x 17924978
48. M Simon JP Bostrom C Hartmann 2007 Molecular genetics of meningiomas: from basic research to potential clinical applications Neurosurgery 60 787 798 10.1227/01.NEU.0000255421.78431.AE 17460514 discussion 787-798
49. J Bostrom B Meyer-Puttlitz M Wolter, et al. 2001 Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas Am J Pathol 159 661 669 1:CAS:528:DC%2BD3MXms1Wit7w%3D 11485924
50. A Perry R Banerjee CM Lohse BK Kleinschmidt-DeMasters BW Scheithauer 2002 A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas Brain Pathol 12 183 190 1:CAS:528:DC%2BD38XlvVSjtLg%3D 11958372